Cargando…
Neo-Fs Index: A Novel Immunohistochemical Biomarker Panel Predicts Survival and Response to Anti-Angiogenetic Agents in Clear Cell Renal Cell Carcinoma
SIMPLE SUMMARY: Although anti-angiogenetic agents (AAA) are mainstay treatments for clear cell renal cell carcinoma (ccRCC), there are very few histology-based predictive biomarkers applicable in routine clinical practice. Considering that frameshifts contribute to antitumor immunity and ccRCC harbo...
Autores principales: | Kim, Jisup, Park, Jee-Young, Shin, Su-Jin, Lim, Beom Jin, Go, Heounjeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000111/ https://www.ncbi.nlm.nih.gov/pubmed/33801954 http://dx.doi.org/10.3390/cancers13061199 |
Ejemplares similares
-
Immunohistochemical panel for differentiating renal cell carcinoma with clear and papillary features
por: Alshenawy, Hanan AlSaeid
Publicado: (2015) -
Angiogenetic Factors in Chronic Subdural Hematoma Development
por: Petrov, Andrey, et al.
Publicado: (2022) -
Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heart
por: Klopsch, Christian, et al.
Publicado: (2018) -
Inhibition of angiogenetic macrophages reduces disc degeneration-associated pain
por: Hou, Yang, et al.
Publicado: (2022) -
Anti-Angiogenetic and Anti-Lymphangiogenic Effects of a Novel 2-Aminobenzimidazole Derivative, MFB
por: Hsu, Ming-Jen, et al.
Publicado: (2022)